Note - The product information found within this database originates from organizations not subject to the Official Languages Act and is available in the language in which it was written and submitted to Health Canada.

Note - The market status of a product is now available in the LNHPD and identifies if a product is "marketed" or "not marketed" in Canada. Product licence holders may voluntarily provide the Natural and Non-Prescription Health Products Directorate (NNHPD) with information about whether their product is currently available to Canadian consumers. Where no information has been provided, the default status is "not marketed". The "current status" field remains unaffected and will continue to indicate the status of the product licence (i.e., active, discontinued, stop sale, cancelled, or suspended). Note that where a licence has been suspended, cancelled or under stop sale, the product cannot be legally sold in Canada.

Product licence holders - if you wish to update a product's market status, you are invited to complete the Natural Health Products Market Notification Web Form. As with all other notifications, there is no current service standard. The NNHPD will process the market status update as soon as feasible, based on its available resources. As a reminder, market notification is voluntary; therefore, a licence holder is not required to wait for the LNHPD to be updated before a licensed product is sold in Canada. As such, products that are identified in the LNHPD as "not marketed" may still be sold in Canada.

New search

Natural Product Number (NPN):

80013007

Market status:

Marketed

Licence Status:

Active

Brand name(s):

JAMP - K 20 ;
JAMP K20

Licence holder:

JAMP Pharma Corporation

Dosage Form:

Tablet, Extended Release

Recommended route of administration:

Oral

Recommended use or purpose:

Supplemental oral potassium for the treatment or prevention of hypokalemia, potassium replacement therapy. and electrolyte replenisher.

Risk Information:

Cautions and Warnings 

Consult a physician prior to use if you have impaired renal function as the use of potassium supplements must be monitored closely. The use of potassium supplements with potassium sparing diuretics (spironalactone, triamterene, amiloride) may lead to hyperkalemia. Warning: A probable association exists between the use of coated tablets containing potassium salts, with or without thiazide diuretics, and the incidence of serious bowel ulceration. Such preparations should be discontinued if abdominal pain, distention, nausea, vomiting or gastrointestinal bleeding occur.

Contra-Indications 

Do not use this product with other potassium-containing supplements or with potassium-containing salt-substitutes

List of medicinal ingredients:

Medicinal ingredients	Quantity (Qty)	Extract	Potency
Potassium	20.0 mEq

List of non-medicinal ingredients:

• Calcium phosphate, dibasic, dihydrate
• Eudragit RS
• Glycerin
• Hypromellose
• Magnesium Stearate
• Polyethylene Glycol
• Polyvinylpyrrolidone
• Talc
• Titanium dioxide
• Xanthan Gum

Date of licensing:

2009-09-10

Revised date of licence:

2024-05-08